These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 3747914)
1. Drug disposition and dosing in hepatic disease. Somogyi A; Rolan P Med J Aust; 1986 Sep; 145(6):284-6, 289. PubMed ID: 3747914 [No Abstract] [Full Text] [Related]
2. Drug disposition in liver disease. Fruncillo RJ Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640 [No Abstract] [Full Text] [Related]
3. Drug disposition and liver disease. Wilkinson GR; Schenker S Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104 [No Abstract] [Full Text] [Related]
4. [Side effects of drugs--predictable hazards for patients with liver disease]. Baumgarten R Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279 [No Abstract] [Full Text] [Related]
5. Hepatic circulation and drug disposition in cirrhosis. Shand DG Gastroenterology; 1979 Jul; 77(1):185-6. PubMed ID: 447017 [No Abstract] [Full Text] [Related]
6. Drug disposition in liver disease. Shand DG N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536 [No Abstract] [Full Text] [Related]
7. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test. Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671 [TBL] [Abstract][Full Text] [Related]
8. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Farrell GC; Cooksley WG; Hart P; Powell LW Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827 [TBL] [Abstract][Full Text] [Related]
9. Impairment of hepatic drug metabolism in patients with acute viral hepatitis. Narang AP; Datta DV; Nath N; Mathur VS Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177 [TBL] [Abstract][Full Text] [Related]
10. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery. Chauhan CK; Nanivadekar SA; Billimoria FR Indian J Physiol Pharmacol; 1989; 33(1):63-6. PubMed ID: 2737749 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics in liver cirrhosis]. Ackermann E Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389 [TBL] [Abstract][Full Text] [Related]
13. Effects of liver disease and of aging on the disposition and elimination of sedatives. Schenker S Trans Am Clin Climatol Assoc; 1978; 89():91-9. PubMed ID: 30206 [No Abstract] [Full Text] [Related]
14. Altered hepatic blood flow and drug disposition. Nies AS; Shand DG; Wilkinson GR Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954 [TBL] [Abstract][Full Text] [Related]
15. [Handling of drugs by cirrhotic patients]. Danan G; Pariente A Rev Prat; 1986 Sep; 36(39):2298-308. PubMed ID: 3809928 [No Abstract] [Full Text] [Related]
16. Clearance and biologic half-life as indices of intrinsic hepatic metabolism. Perrier D; Gibaldi M J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599 [No Abstract] [Full Text] [Related]
17. [Metabolism of phenylbutazone in the liver (author's transl)]. González Macías J; De Castro del Pozo S Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107 [TBL] [Abstract][Full Text] [Related]
18. The daily rhythm of cortisolemia in hepatic cirrhosis. Ruzyllo E; Dzieniszewski J; Milewski B; Krygier T Mater Med Pol; 1973; 5(1):9-16. PubMed ID: 4774849 [No Abstract] [Full Text] [Related]